Cohance Lifesciences Ltd
No trades
Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—
8.10 INR
2.68 B INR
11.80 B INR
162.29 M
About Cohance Lifesciences Ltd
Sector
Industry
Website
Headquarters
Hyderabad
Founded
2018
IPO date
Mar 9, 2020
Identifiers
2
ISIN INE03QK01018
Cohance Lifesciences Ltd. manufactures chemical products. It specializes in providing pharmaceutical solutions to global life science companies. The firm engages in Contract Research & Manufacturing Services (CRMS) business where research and development is customized to the needs of global pharmaceutical customers. Its business segments include pharmaceutical solutions, active pharma ingredients, intermediates and formulations. The company was founded on November 6, 2018 and is headquartered in Hyderabad, Telangana.
Related stocks
Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Displays a symbol's price movements over previous years to identify recurring trends.
MOSMALL250
Motilal Oswal Nifty Smallcap 250 ETF Units Exchange Traded FundWeight
0.43%
Market value
68.55 K
USD
HESC
HSBC ETFs PLC - HSBC MSCI Emerging Markets Small Cap Screened UCITS ETFWeight
0.03%
Market value
14.60 K
USD
MULTICAP
Mirae Asset Nifty500 Multicap 502525 ETF Exchange Traded Fund UnitsWeight
0.11%
Market value
7.35 K
USD
Explore more ETFs
Frequently Asked Questions
The current price of COHANCE is 339.45 INR — it has decreased by −4.86% in the past 24 hours. Watch Cohance Lifesciences Ltd stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on NSE exchange Cohance Lifesciences Ltd stocks are traded under the ticker COHANCE.
COHANCE stock has fallen by −9.49% compared to the previous week, the month change is a −32.62% fall, over the last year Cohance Lifesciences Ltd has showed a −69.53% decrease.
We've gathered analysts' opinions on Cohance Lifesciences Ltd future price: according to them, COHANCE price has a max estimate of 1,150.00 INR and a min estimate of 500.00 INR. Watch COHANCE chart and read a more detailed Cohance Lifesciences Ltd stock forecast: see what analysts think of Cohance Lifesciences Ltd and suggest that you do with its stocks.
COHANCE reached its all-time high on Dec 2, 2024 with the price of 1,360.00 INR, and its all-time low was 87.60 INR and was reached on Mar 24, 2020. View more price dynamics on COHANCE chart.
See other stocks reaching their highest and lowest prices.
See other stocks reaching their highest and lowest prices.
COHANCE stock is 6.67% volatile and has beta coefficient of 0.65. Track Cohance Lifesciences Ltd stock price on the chart and check out the list of the most volatile stocks — is Cohance Lifesciences Ltd there?
Today Cohance Lifesciences Ltd has the market capitalization of 129.84 B, it has decreased by −1.47% over the last week.
Yes, you can track Cohance Lifesciences Ltd financials in yearly and quarterly reports right on TradingView.
Cohance Lifesciences Ltd is going to release the next earnings report on Feb 12, 2026. Keep track of upcoming events with our Earnings Calendar.
COHANCE earnings for the last quarter are 1.92 INR per share, whereas the estimation was 1.55 INR resulting in a 23.87% surprise. The estimated earnings for the next quarter are 2.69 INR per share. See more details about Cohance Lifesciences Ltd earnings.
Cohance Lifesciences Ltd revenue for the last quarter amounts to 5.56 B INR, despite the estimated figure of 5.85 B INR. In the next quarter, revenue is expected to reach 6.14 B INR.
COHANCE net income for the last quarter is 740.80 M INR, while the quarter before that showed 488.80 M INR of net income which accounts for 51.55% change. Track more Cohance Lifesciences Ltd financial stats to get the full picture.
Cohance Lifesciences Ltd dividend yield was 0.00% in 2024, and payout ratio reached 0.00%. The year before the numbers were 0.00% and 0.00% correspondingly. See high-dividend stocks and find more opportunities for your portfolio.
As of Feb 8, 2026, the company has 2.29 K employees. See our rating of the largest employees — is Cohance Lifesciences Ltd on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. Cohance Lifesciences Ltd EBITDA is 4.24 B INR, and current EBITDA margin is 33.84%. See more stats in Cohance Lifesciences Ltd financial statements.
Like other stocks, COHANCE shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Cohance Lifesciences Ltd stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So Cohance Lifesciences Ltd technincal analysis shows the strong sell today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating Cohance Lifesciences Ltd stock shows the sell signal. See more of Cohance Lifesciences Ltd technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.